To see whether age-related changes in bone could predict subsequent lifespan, we measured multiple aspects of femur size and shape at 4, 15, and 24 months of age in genetically heterogeneous mice. Mice whose cortical bone became thicker from 4 to 15 months, associated with preservation of the endosteal perimeter, survived longer than mice whose endosteal cavity expanded, at the expense of cortical bone, over this age range. Femur size at age 4 months was also associated with a difference in life expectancy: mice with larger bones (measured by length, cortical thickness, or periosteal perimeter) had shorter lifespans. Femur length, midlife change in cortical bone thickness, and midlife values of CD8 T memory cells each added significant power for longevity prediction. Mice in the upper half of the population for each of these three endpoints lived, on average, 103 days (12%) longer than mice with the opposite characteristics. Thus, measures of young adult bone dimensions, changes as a result of bone remodeling in middle age, and immunological maturation provide partially independent indices of aging processes that together help to determine lifespan in genetically heterogeneous mice.
Introduction
Studies in rodents and humans have documented thousands of traits that change with age in adult life, but have been notably less successful (Sprott, 1999; Miller, 2001a; Johnson, 2006) in providing evidence of early and midlife traits that can predict the length of healthy lifespan and the rate of aging. Many studies have documented risk factors for specific late-life diseases and assessment of obesity, glucose tolerance, hypertension, and history of previous infarction, hip fracture, or neoplasia are routinely incorporated into clinical practice on the basis of their predictive power. In contrast, studies of how lifespan can be influenced by early developmental processes, and midlife rates of change, are difficult to conduct in a species with a mean lifespan over 70 years. Although the shorter lifespan of rodents has the potential to speed up such assessments, they depend upon the development of methods that can assess relevant physiological traits, preferably at several points over the life course, without harm to the mouse.
The availability of in vivo micro-CT instrumentation that can provide accurate assessments of mouse bone dimensions and mineral content provided an opportunity to assess whether early and midlife variation in bone properties could predict longevity. We have conducted a longitudinal study using 519 mice, bred by a four-way cross scheme (Jackson et al., 1999; Volkman et al., 2003) so that the population would be molded by both genetic and nongenetic influences. We chose to use this heterogeneous population, called 'UM-HET3,' for this study for several reasons. UM-HET3 mice have been used in several previous studies (Volkman et al., 2003 (Volkman et al., , 2004 Reeves et al., 2007) to map genes related to the morphology and mechanical properties of the femur and the vertebrae, thus providing a good deal of prior information about bone biology on which to base our experimental design and with which to compare our current results. Secondly, we have also used UM-HET3 mice for several previous studies of phenotypes that are predictive of lifespan and have shown that both body size and midlife T-cell subset patterns (Miller & Chrisp, 2002; Harper et al., 2004) can predict lifespan of individual animals. Thus, we selected the UM-HET3 population for an analysis of whether changes in bone morphology at various stages of adult life have implications for lifespan. We also hope that observations made using genetically heterogeneous populations may have broader applicability, both for experimental animals and for human biology, than studies based on mice of a single, potentially idiosyncratic genotype . Lastly, we were aware that the NIA has selected the UM-HET3 population for its Intervention Testing Program and therefore believe that information about bone development in aging UM-HET3 mice can serve as a foundation for studies of anti-aging drugs and their possible effects on bones.
We report that measurements of the rate of midlife change in endosteal perimeter and cortical thickness of the femur predict subsequent longevity, and that measurements of femoral size at 4 months provide additional, independent, predictive power.
Measures of femur size, endosteal preservation, and an age-sensitive T-cell subset can separate mice into groups that differ by 12% in median lifespan.
Results
Among the 519 mice evaluated, 10% died prior to 656 days, median survival was 880 days, and 90% died prior to 1061 days. The oldest mouse survived to 1296 days. Measurements taken at 15 and 24 months correspond to ages at which survival was, respectively, 99% and 80% among the 519 mice with bone data and recorded ages at death. Thus, values measured on mice at 24 months of age may not be representative on the entire test population, but only on the 80% that survived as long as 2 years.
Tests for femur length, cross-sectional area, cortical thickness, periosteal perimeter, endosteal perimeter, and bone mineral content were recorded at 4 months of age for 519 mice whose date of death was subsequently recorded. Table 1 presents the mean levels (with sem) for each of these endpoints. Cox regression calculations were used to determine which of these characteristics was associated with differences in survival and mortality risk, and Table 1 shows the hazard ratios (HR) and P-values for each trait. High values of length, cross-sectional area, cortical thickness, periosteal perimeter, and bone mineral content were all associated with shorter lifespan, with unadjusted P-values ranging from P = 0.003 for bone mineral content to P < 0.001 for length and cross-sectional area. Each of these measures is positively correlated with each of the others, with regression coefficients ranging from 0.36 to 0.91, and each is a measure of femur size or robustness. A principal factors calculation (not shown) showed that the first principal factor had positive loadings on each of these endpoints (0.5 for length and > 0.8 for all other measures), and an eigenvalue of 3.5. In a Cox regression model, this first principal factor was significantly associated with mortality risk (HR = 1.18, P < 0.001). We conclude that mice with larger femurs have elevated mortality risk after age 4 months.
The pattern of associations between bone traits and longevity is altered, however, in mice tested at 15 months. Mean levels for each trait are shown in Table 1 , for each of the 505 mice that survived to be tested in middle age. Of the five traits that were, at 4 months of age, predictors of survival, only length is still a significant predictor when measured at 15 months (HR = 1.4, P = 0.005). Endosteal diameter, which was not associated with lifespan when measured in 4 month old mice, is a significant predictor measured in 15-month-old animals (HR = 1.7, P < 0.001). High endosteal diameter values identify mice with shorter life expectancy. Table 1 also shows mean values for each of these traits measured in 24-month-old mice; 416 mice survived to be tested at this age. Although high values of cortical thickness were associated with low life expectancy at 4 months (at P = 0.003), high cortical thickness levels were associated with significantly greater life expectancy (P = 0.005) when measured in mice at 24 months of age, a reversal of the direction of the association. A similar reversal was seen for cross-sectional area, with high levels associated with shorter lifespan at 4 months (P < 0.001), but with a trend toward association of longer lifespan to lower levels (P = 0.08, not significant) when cross-sectional area is measured in 24-month-old animals. The association between good survival and low endosteal perimeter levels, seen at 15 months of age, is even stronger at 24 months of age (Cox regression HR of 1.7 and 2.2, respectively). Table 2 shows an alternate approach to evaluating intermouse differences in bone aging and mortality risks. For each trait, we calculated a change score by subtracting the 4-month value from the 15-month value for each of the 449 mice that were measured at each age. Mean values of these change scores are shown in Table 2 , and each was significantly different from zero (the null hypothesis) at P < 0.0001. We conclude that each of these bone traits is sensitive to age, between 4 and 15 months, in these genetically heterogeneous mice. Four of these change scores are significant predictors of remaining lifespan in Cox regression analyses (Table 2) . Lower mortality risks, and thus longest lifespans, are seen in 15-month-old mice that exhibit the largest changes in cross-sectional area, cortical thickness, and bone mineral content, and with the smallest change in endosteal perimeter.
We calculated a similar set of change scores to evaluate changes between 15 and 24 months of age, for the 369 mice that were evaluated at each age ( Table 2) . Each of these change scores is significantly different from zero at P < 0.0001, except for cortical thickness (P = 0.08 for change score); this is consistent with the idea that length, cross-sectional area, periosteal perimeter, endosteal perimeter, and bone mineral content continue to increase between 15 and 24 months of age, although interpretation of these values is complicated by the absence of information on the 20% of mice that died prior to 24 months. Among mice that survived to 24 months, high rates of change in endosteal perimeter are again associated with lower remaining life expectancy, as noted for changes between 4 and 15 months of age. None of the other change scores from 15 to 24 months was significantly associated with subsequent mortality risk. Figure 1 shows scatterplots relating lifespan to cortical thickness change scores and endosteal perimeter change scores, from 4 to 15 months, among individual mice. Those mice whose cortical thickness declines from 4 to 15 months (cortical thickness change score < 0) tend to die at earlier ages than those whose cortical thickness values are above zero. Similarly, mice that have the largest increase in endosteal perimeter in this age range (high endosteal perimeter change scores) tend to die at early ages compared to mice whose endosteal perimeter does not change or decreases in midlife. Change score is calculated as the value at the older age minus the value at the younger age in the same animal. SEM = standard error of the mean. Each change score is significantly different from zero at P < 0.0001. HR, hazard ratio from Cox regression using the change score as independent variable. N = number of mice evaluated at the indicated age. Up arrow indicates that high change scores are associated with improved life expectancy. Down arrow fl indicates that low change scores are associated with improved life expectancy. P-values are nominal, i.e. they have not been adjusted for multiple comparisons. The analyses mentioned previously suggested that bone traits were associated with survival in two ways: (i) small femurs in 4-month-old mice were predictive of better survival and (ii) preservation or increase in femur cortical thickness in midlife was predictive of better survival. To see whether these two sets of changes provided independent predictive power, we evaluated a series of bivariate Cox regression models, each combining a measure of bone size at 4 months with an index of change between 4 and 15 months. The strongest association (evaluated by likelihood ratio v 2 ) was for the combination of length at 4 months and the cortical thickness change score. Length was associated with a hazard ratio of 1.37 (P = 0.005) and cortical thickness change score with a hazard ratio of 0.03 (P = 0.002). Figure 2 provides an illustration of the survival patterns for subsets of mice distinguished by one or both of these predictors. Mice divided into two groups on the basis of length at 4 months (left panel) differ by 47 days in median survival (P = 0.001 by log-rank test comparing mice with high or low levels of length). Cortical thickness change score, by itself, divides mice into two groups that differ by 28 days in median lifespan (not shown). The middle panel of Fig. 2 compares survival curves for mice that are in the lower half for length and also in the upper half for cortical thickness change score to those with the opposite category for both traits. Mice with low levels of length (4) and high levels of the cortical thickness change score live on average 78 days longer than mice with the opposite phenotype (see Fig. 2 , middle panel).
Prediction of lifespan by a combination of bone and immune predictors
Studies of earlier populations of UM-HET3 mice had shown that mice with elevated levels of memory T cells, at 18 months of age, had shorter lifespans than mice with lower memory T-cell fractions . We therefore thought it would be of interest to discover whether the two classes of predictor variables, i.e. immune and bone endpoints, would provide independent predictive power in Cox regression models. In the current group of UM-HET3 mice, the fraction of CD8 cells with the memory phenotype (CD8M), measured at 18 months of age, was again associated with differences in remaining lifespan (HR = 1.01; P = 0.002 by Cox regression). Populations divided by the median level of CD8M differed by 36 days in their median survival (not shown). To see whether this measure of age-sensitive immune status provided additional predictive power beyond that available from bone traits alone, we performed a Cox regression that included length (at 4 months), cortical thickness change score (from 4 to 15 months), and CD8M levels (at 18 months). Table 3 shows the results of the regression calculation. Each of these traits added significant power to the overall regression at 0.01 < P < 0.03. Each individual measurement can divide the population into halves that differ by 47, 28, or 36 days in median lifespan. When mice are classified on all three indices, however, those with the optimal combination (short Hazard ratios and associated P-values for a Cox regression model with three predictors: Length at 4 months, cortical thickness change score from 4 to 15 months, and CD8 memory cell value at 18 months. Effect size (univariate) indicates difference in median lifespan between mice in the top or bottom half of the distribution for each predictor variable considered separately. Right-hand column gives difference in median lifespan between mice with above or below the median values for each of the three predictors and corresponds to the survival curve shown in Fig. 2 (right panel).
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ª 2011 The Authors Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland femur length at 4 months, greatest change in cortical thickness between 4 and 15 months, and lowest number of CD8 memory cells at 18 months) have a median survival that is 103 days longer than the group with the opposite set of traits. This value is 12% of the median lifespan for the population as a whole. The right panel of Fig. 2 shows survival curves for these two mouse subpopulations.
The Wang-Allison method (Wang et al., 2004) was used to evaluate differences between these subpopulations in extreme survival. The two subpopulations shown in Fig. 2 (right panel) had a joint survival distribution for which only 10% of the mice lived more than 1074 days. At this age, 3 ⁄ 68 (4%) mice in the shorter-lived population still survived, compared to 10 ⁄ 60 (17%) of the longer-lived group; this difference is significant at P = 0.022 by Fisher's exact test. We conclude that a combination of bone and immune predictors can divide the population into subsets that differ in maximal lifespan.
Correlation between immune and bone predictors
Lastly, we evaluated the question of whether mice that preserve femoral bone in midlife also preserve youthful immune status, a hypothesis consistent with the idea that each of these indices provides information about inter-mouse differences in rate of aging. Mice with low levels of CD8M were indeed found to have relatively high levels of cortical thickness change score (R = )0.1, P = 0.03) and low levels of endosteal perimeter (measured at 15 months) (R = 0.12, P = 0.01). Both relationships are in the predicted direction, in that mice with youthful CD8M levels also have values for endosteal perimeter and cortical thickness change scores that are associated with longer survival. The association is in each case statistically significant, but small in size.
Discussion
Micro-CT methods now permit serial assessment of bone geometry in individual mice as they age. We have shown here that measurements of bone size and shape can predict mouse lifespan at ages well below the median age at death. The spectrum of traits that have predictive value changes with age: for some traits, like cortical thickness, high values can be predictive of longevity at one age and low values at other ages. We found that combinations of bone measures and age-sensitive immune endpoints can divide the population into subsets that differ in median lifespan by as much as 100 days, with significant difference in maximal lifespan. The study was conducted in genetically heterogeneous mice to provide sources of both genetic and nongenetic differences and to facilitate a later search for genetic polymorphisms relevant to bone aging and mouse longevity.
Traits that predict life expectancy can, in principle, emerge from at least three categories, each with its own implications for biology of bone development, disease risk, and aging.
1. Some traits may serve as indicators of risk of specific lethal illnesses; these are the classical 'risk factors.' Head trauma, for example, is a well-known risk factor for some forms of human neurodegenerative disease, just as are inherited alleles for Huntington's disease. In the area of bone biology, a malformed acetabulum is an important risk factor, in Labrador Retrievers, for late-life hip arthritis, often serious enough to require humane euthanasia of the animal. Disease-specific risk factors of this kind do not provide useful information about the biology of the aging process and its regulation, despite their importance as clues to the risk, and in some cases the pathogenesis, of important and potentially fatal illnesses.
2. A second class of predictors consists of traits that may indeed be closely related to inter-individual differences in aging, regardless of the effects of aging on the trait itself. Among dogs, Fig. 3 The overall whole-bone femoral length was calculated from thresholded microCT images. Geometric analyses were performed on a standardized 3-mm mid-diaphyseal segment within the left femora. Crosssectional area, cortical thickness, and periosteal and endosteal perimeters were measured at 4, 15, and 24 months. for example, smaller purebred dogs tend to live much longer than dogs of larger breeds (Li et al., 1996; Michell, 1999) , and small stature is also associated with longer lifespan among nonpurebred dogs (Patronek et al., 1997) . Similarly, short stature in humans is associated with a dramatic reduction in risk of most forms of neoplasia (Albanes et al., 1988; Tretli, 1989; Hebert et al., 1993; Tretli & Robsahm, 1999; Davey et al., 2000; Petrelli et al., 2002) . The association between short stature and increased longevity in dogs is associated with, and presumably reflects, resistance of shorter dogs to many forms of illness, including cataracts (Williams et al., 2004) , lethal cardiovascular, neurological, and neoplastic disease (Bonnett et al., 2005) , and other geriatric complaints (Hoskins & McCurnin, 1997) . Small body size is also associated with higher life expectancy among related breeds of mice (Miller et al., 2000) and among individual mice of the UM-HET3 stock . It is plausible, though not proven, that some of the differences among mouse stocks, mice, and dog breeds in life expectancy might represent effects of growth hormone and ⁄ or IGF-1, in that single-gene mutations that inhibit growth hormone (GH) and IGF-1 signals often lead to improved longevity in mice (Brown-Borg et al., 1996; Coschigano et al., 2000; Flurkey et al., 2001) , as well as to postponement of many of the lethal and nonlethal consequences of aging (Flurkey and Harrison, 1990; Kinney et al., 2001; Ikeno et al., 2003; Vergara et al., 2004) . Differences among individuals, or breeds, in body stature or in underlying GH ⁄ IGF levels (Eigenmann et al., 1984) , may lead to differences in aging rate and thus modulate incidence and severity of a wide range of age-related traits and diseases, whether or not size and hormone levels change systematically with age. Measurements of bone size and robustness, taken early in adult life, fall into this category.
3. The third class of predictors, conceptually, might represent variables that are age-sensitive in adults, and whose pace of change in adult life can serve as a surrogate for the pace of the underlying aging process (Miller, 2001a) . Such predictors can be considered 'biomarkers' of aging, in the same sense that blood alcohol level can be considered a biomarker for recent consumption of alcoholic beverages, i.e. as an easily measurable index of an unobserved process (aging or drinking). It is easy to construct a set of biomarkers that distinguish long-lived from short-lived dog breeds: an individual dog that reaches age 6 or 8 years without any evidence of cataract, arthritis, anosmia, presbycusis, or cardiovascular decline can be considered to be aging more slowly than a dog with problems in most of these age-sensitive systems. Biomarkers of aging, like risk factors for disease, may well be associated statistically with altered life expectancy, but are also expected to have predictive power for a wide range of age-sensitive traits unrelated to specific lethal illnesses. It has been remarkably difficult to validate biomarkers of aging that are distinct from disease-specific risk factors (class 1) and from surrogates for processes that control aging rate (class 2).
We believe that the bone traits listed in Table 1 include representatives of two of these three classes. The measurements taken at age 4 months reflect, we think, different estimators of overall robustness and size; these are all correlated with one another and are all associated with lifespan in the same direction. Long femur length, large cross-sectional area, thick cortical bone, long periosteal diameter, and high bone mineral content are all seen in mice destined for relatively short lives. The ability of these measures, taken at 4 months of age, to predict life expectancy seems likely to represent the influence of some underlying physiological factor, possibly related to the GH ⁄ IGF-1 axis, with effects on both aging and bone morphology.
The predictive factors that attain significance only in midlife, however, may well be of another type, class 3, i.e. biomarkers of the pace of aging. In 15-month-old mice, those with the largest periosteal diameters have the shortest life expectancy, and by 24 months, high values for cortical bone thickness, originally associated with poor survival, are now significantly associated with higher life expectancy. Measures of cross-sectional area show a similar pattern: a negative association with survival when measured at 4 months and a positive (although not significant at P = 0.08) association at the 24-month time point. All three of these measures provide related information about the size of the marrow cavity, the thickness of the remaining cortical bone, and the relative ability of bone-forming process in the interior of the femur to keep pace with bone resorption. Thus, optimal survival is seen in mice that have relatively small femurs when young (low values for cortical thickness, cross-sectional area, and periosteal perimeter as well as length), but which retain as much bone thickness as possible at oldest ages and thus have relatively high values for cortical thickness and low values for endosteal perimeter. The bivariate regression analysis shows that measurements sensitive to bone remodeling between 4 and 15 months of age add predictive power beyond models that rely only on indices of bone size at age 4 months.
Neither variety of bone measurement is a plausible candidate for a risk factor for lethal disease in UM-HET3 mice. Terminal necropsies have been reported for 886 UM-HET3 mice (Lipman et al., 2004) , including 344 virgin females. Most of these mice die of neoplasms, including fibrosarcoma, hemangiosarcoma, lymphoma, and pulmonary adenocarcinoma. Nonneoplastic illnesses can account for death in about 6% of the virgin females. It seems very unlikely that inter-animal differences either in bone size, or in midlife bone remodeling, contribute to the risk of these terminal illnesses. We therefore favor the hypothesis that differences in the pace at which cortical bone thickness is lost (and endosteal perimeter increased) are related to differences among the mice in the rate of aging, which in turn affects risks and severity of lethal diseases in these animals.
Our data show a correlation between the rate of bone remodeling and survival in mice. There appear to be two distinct varieties of bone remodeling, likely to differ in their mode of regulation and their functional consequences. The first is targeted remodeling, a mechanism to respond to the need for maintaining mechanical integrity, including the repair of microdamage in humans. The second is stochastic remodeling, associated with metabolic homeostasis, providing access to stored chemical constituents such as calcium (Burr & Martin, 1993; Han , 1997; Parfitt, 2002) . Stochastic remodeling is regulated by hormones and a variety of growth factors, while targeted remodeling has been reported as a response to osteocyte apoptosis (resulting from microdamage and continued mechanical usage), habitual mechanical demand, and changes in the extracellular matrix with advanced age (Burr, 2002; Heaney, 2003; Noble, 2003; Waldorff et al., 2010) . Independent of the remodeling mechanism, however, it has been proposed that the local process of remodeling results in a local net loss in bone volume (Parfitt, 2002) . This proposed loss of bone with remodeling, supported by histological observations, occurs despite the tight coupling known to exist between bone resorption and formation. As a result, a substantial increase in remodeling rate has been correlated to an increase in bone loss. This phenomenon is particularly apparent in the dramatic increase in rate of bone loss in human females during the peri-and postmenopausal years. Similar loss of bone is observed in mouse models of estrogen deficiency as a result of ovariectomy (Alexander et al., 2001; Bouxsein et al., 2005) . Interestingly, the rate or extent of bone loss because of decrease in estrogen has been observed to be species specific and is hypothesized to be partly genetically regulated (Iwaniec et al., 2006) . Within the context of this paper, the maintenance of cortical thickness and endosteal diameter in longer-lived mice suggests that a slower pace of remodeling is associated with survival, and that the rate of age-related bone change may be controlled by processes that also influence the age of occurrence of other late-life illnesses, including those that lead to death in UM-HET3 mice. It is important to clarify this perspective and hypothesis. The observed changes to bone on the endosteal and periosteal surfaces might also be considered a modeling drift, as they may be occurring independently on different surfaces. Considering the advanced age of the mice, however, we suspect that these findings are, in fact, a result of a variation in remodeling occurring on both the endosteal and periosteal surfaces. This proposed bone remodeling is likely to reflect interactions among many regulatory pathways, including changes in hormones and hormonal receptors, damage resistance in the extracellular matrix, osteocyte resistance to apoptosis, and factors that influence signaling for osteoclastogenesis and stem cell differentiation. Clearly, these provide valuable avenues for future investigation, as well as the need to verify whether the observations are a result of remodeling or a modeling drift.
Inter-animal variation in the levels of CD8 memory T cells (as a proportion of CD8 T cells) provides additional predictive power when added to regression models that include femur length, retained cortical bone thickness, or both bone variables. We have shown previously that age-sensitive T-cell subsets Miller, 2001b; Miller & Chrisp, 2002; Harper et al., 2004) , including memory cells of the CD4 and CD8 lineages, in both spleen and blood, can predict lifespan in genetically heterogeneous mice. In the current population, the CD8M subset has independent predictive value in regression models that already contain both kinds of bone information. When the mice are divided into subsets distinguished by the median values of all three predictors, the 1 ⁄ 8th of the mice with the most favorable combination has a median life expectancy more than 100 days above that of the 1 ⁄ 8th of the mice with the opposite set of predictors and differs significantly in a surrogate for maximal lifespan [the Wang-Allison test (Wang et al., 2004) ]. The simplest interpretation is that the factors that modulate age-dependent T-cell changes are at least in part distinct from those that influence early and midlife variation in femoral bone.
The challenge of finding mid-life endpoints that can serve as surrogate markers for differences in rate of aging, so easy to meet in studies across species and across breeds of long-lived vs. short-lived dogs, is still a live issue in rodent and human biogerontology. Further developments in this domain would help address the theoretical issue of whether individual mice, or individual people, do in fact age at varying rates and at the same time provide a practical tool for screening putative anti-aging drugs to find candidates for further detailed and costly analyses.
Experimental procedures Mice
Genetically heterogeneous mice were produced by a cross between (C57BL ⁄ 6J · BALB ⁄ cJ)F1 males and (C3H ⁄ HeJ · DBA ⁄ 2J)F1 females. Mice of this variety are called UM-HET3 in previous publications and have been used to document genetic polymorphisms that control femoral and vertebral dimensions, and mechanical fragility in 18-month-old mice (Volkman et al., 2003 (Volkman et al., , 2004 Reeves et al., 2007) , as well as genetic variation relevant to immune aging (Jackson et al., 1999; Miller et al., 2003) , and for the evaluation of immunological predictors of lifespan Miller & Chrisp, 2002) . With respect to nuclear genes, each mouse in the population can be considered a full sib of each other mouse, sharing a random 50% of its genetic inheritance. This study used only female mice, bred over a period of 24 months, housed in groups of four mice per cage, and given free access to water and mouse chow. The colony was evaluated every 3 months to document its specific-pathogen-free status as previously described ; all such tests were negative throughout the experiments reported here. In addition to the bone assessments described later, each mouse was subjected to a tail-tip biopsy for genotyping (to be reported elsewhere) and subjected to tail venipuncture at 18 months to provide blood for T-cell evaluation. Mice were inspected daily for general health, and age at death was recorded for those found dead. Mice found to be extremely ill were euthanized if, in the judgment of an experienced caretaker, they were thought unlikely to survive more than another day; in these cases, the date of euthanasia was used to calculate age at death.
The experimental population initially consisted of 600 mice. Fifteen of these died prior to 1 year of age, and because of technical errors, no age at death was recorded for three others. Of the remaining 582 mice, 567 had died by the date of analysis, and 15 (3%) were still alive (right censored in Cox regression analyses). Of these, 519 mice had micro-CT scans at 4 months of age, and the analysis is thus based on assessment of these 519 animals.
MicroCT
Mice were placed into an induction chamber of 2-5% isoflurane gas (MWI Veterinary Supply). Once the mice were fully anesthetized, they were positioned and secured in the prone position on the scanning bed and maintained on 2% isoflurane gas through a nose cone throughout the imaging. The mice were imaged at 4, 15, and 24 months of age using an eXplore Locus in-vivo micro-computed tomography (microCT) scanner (GE Healthcare Pre-Clinical Imaging, London, ON, Canada). This system features a high-precision gantry system that rotates the X-ray source and detector continuously around the anesthetized animal. Scan protocols are short in duration to limit the radiation dose to the animals, particularly important in longitudinal studies such as this. Images were reconstructed at a 45 micron isotropic voxel size. Histograms were generated to select a global mineralized tissue threshold that delineated bone from all other tissues. Geometric and densitometric analyses were performed on a standardized 3-mm mid-diaphyseal segment in the left femora of each animal at each time point. The selected bone volume of interest was analyzed to determine the transverse properties including, cross-sectional area, cortical thickness, endosteal and perisoteal perimeters, and bone mineral content. The variables are schematically illustrated in Fig. 3 and summarized along with their abbreviations in Table 4 .
T-cell subsets
The proportion of peripheral blood CD8 T cells that express high levels of the memory cell marker CD44 was evaluated in each mouse at 18 months of age using flow cytometry as described previously (Jackson et al., 1999; Miller & Chrisp, 2002) . This proportion is referred to as the CD8M value in this paper.
Statistical methods
Tabulated average values are shown in tables as mean ± standard error of the mean. Change scores are calculated by subtracting the value at the earlier age from the value for the later age, for all mice for which both measurements were available. Inferences about age effects on each bone measurement, in specific age intervals, were evaluated by testing the hypothesis that the corresponding change score was equal to zero. Associations between predictor values (bone measures, change scores, T-cell subsets) and survival were evaluated using Cox proportional hazard regression.
